147 related articles for article (PubMed ID: 36207984)
21. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
22. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.
Holland MM; Bhutiani N; Kruse EJ; Weiss MJ; Christein JD; White RR; Huang KW; Martin RCG
HPB (Oxford); 2019 Aug; 21(8):1024-1031. PubMed ID: 30737097
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
[No Abstract] [Full Text] [Related]
24. Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer.
Månsson C; Brahmstaedt R; Nygren P; Nilsson A; Urdzik J; Karlson BM
Anticancer Res; 2019 May; 39(5):2509-2512. PubMed ID: 31092446
[TBL] [Abstract][Full Text] [Related]
25. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
[TBL] [Abstract][Full Text] [Related]
26. Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma.
Xu K; Chen Y; Su J; Su M; Yan L
J Cancer Res Ther; 2020; 16(2):280-285. PubMed ID: 32474514
[TBL] [Abstract][Full Text] [Related]
27. Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis.
Sugumar K; Hurtado A; Naik I; Hue JJ; Rothermel LD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 May; 24(5):586-595. PubMed ID: 35000842
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
[TBL] [Abstract][Full Text] [Related]
29. Gemcitabine plus concurrent irreversible electroporation
Ma YY; Leng Y; Xing YL; Li HM; Chen JB; Niu LZ
World J Clin Cases; 2020 Nov; 8(22):5564-5575. PubMed ID: 33344547
[TBL] [Abstract][Full Text] [Related]
30. Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer.
Belfiore G; Belfiore MP; Reginelli A; Capasso R; Romano F; Ianniello GP; Cappabianca S; Brunese L
Med Oncol; 2017 Mar; 34(3):38. PubMed ID: 28161827
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
[TBL] [Abstract][Full Text] [Related]
32. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
33. A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma.
Yan L; Chen YL; Su M; Liu T; Xu K; Liang F; Gu WQ; Lu SC
Chin Med J (Engl); 2016 Dec; 129(24):2920-2925. PubMed ID: 27958223
[TBL] [Abstract][Full Text] [Related]
34. Irreversible electroporation of locally advanced pancreatic cancer.
Kwon W; Thomas A; Kluger MD
Semin Oncol; 2021 Feb; 48(1):84-94. PubMed ID: 33648735
[TBL] [Abstract][Full Text] [Related]
35. Irreversible Electroporation-Assisted Resection for Locally Advanced Pancreas Cancer.
Davis JM; Salibi PN; Motz BM; Vrochides D; McKillop IH; Iannitti DA
Surg Innov; 2023 Jun; 30(3):332-339. PubMed ID: 36792137
[TBL] [Abstract][Full Text] [Related]
36. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
38. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
[TBL] [Abstract][Full Text] [Related]
39. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection.
Månsson C; Nilsson A; Nygren P; Karlson BM
Anticancer Res; 2020 May; 40(5):2771-2775. PubMed ID: 32366423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]